High-performance liquid chromatographic-tandem mass spectrometric method for the determination of clemastine in human plasma

A highly sensitive high-performance liquid chromatographic-tandem mass spectrometric method (HPLC–MS–MS) has been developed to quantitate clemastine in human plasma for the purpose of pharmacokinetic studies. Sample preparation was carried out by liquid–liquid extraction using deuterated clemastine...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of chromatography. B, Analytical technologies in the biomedical and life sciences Analytical technologies in the biomedical and life sciences, 2005-02, Vol.816 (1), p.153-159
Hauptverfasser: Horváth, Viola, Tolokán, Antal, Egresi, Andrea, Pap, Tímea, Horvai, George, Balogh-Nemes, Katalin, Klebovich, Imre
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 159
container_issue 1
container_start_page 153
container_title Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
container_volume 816
creator Horváth, Viola
Tolokán, Antal
Egresi, Andrea
Pap, Tímea
Horvai, George
Balogh-Nemes, Katalin
Klebovich, Imre
description A highly sensitive high-performance liquid chromatographic-tandem mass spectrometric method (HPLC–MS–MS) has been developed to quantitate clemastine in human plasma for the purpose of pharmacokinetic studies. Sample preparation was carried out by liquid–liquid extraction using deuterated clemastine as an internal standard. Chromatographic separation used a C18 reversed phase polymer column giving an extremely fast total run time of 2 min. The method was validated and used for the bioequivalence study of clemastine tablets in healthy male volunteers ( n = 28). The lower limit of detection proved to be 0.01 ng/ml for clemastine.
doi_str_mv 10.1016/j.jchromb.2004.11.025
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67372342</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1570023204009419</els_id><sourcerecordid>67372342</sourcerecordid><originalsourceid>FETCH-LOGICAL-c422t-592d082d1c890fac1998db1ad41c935be3aa2281ff9081dbb245ed6738f3964e3</originalsourceid><addsrcrecordid>eNqFkUtrFjEUhoMotlZ_gpKN7mbMdS4rkaJWKLhRcBcyyUknH5PJNMkIgj_e1G-gS1cnkOd9T3iC0GtKWkpo9_7UnsycYphaRohoKW0Jk0_QJR163vC--_m0nmVPGsI4u0Avcj4RQnvS8-fogsquE1zIS_Tnxt_NzQbJxRT0agAv_n73Fv8r1yXeJb3N3jRFrxYCDjpnnDcwpV5DSd7gOuZocS3AZQZsoUAKftXFxxVHh80CNVX8CtiveN7rGrwtOgf9Ej1zesnw6phX6MfnT9-vb5rbb1--Xn-8bYxgrDRyZJYMzFIzjMRpQ8dxsBPVVlAzcjkB15qxgTo3koHaaWJCgu16Pjg-dgL4FXp37t1SvN8hFxV8NrAseoW4Z1XRnnHBKijPoEkx5wRObckHnX4rStSDdnVSh3b1oF1Rqqr2mntzLNinAPYxdXiuwNsD0NnoxaWq2udHrhOS8p5U7sOZg6rjl4eksvFQv8X6VJ0rG_1_nvIXkcOmWg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67372342</pqid></control><display><type>article</type><title>High-performance liquid chromatographic-tandem mass spectrometric method for the determination of clemastine in human plasma</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Horváth, Viola ; Tolokán, Antal ; Egresi, Andrea ; Pap, Tímea ; Horvai, George ; Balogh-Nemes, Katalin ; Klebovich, Imre</creator><creatorcontrib>Horváth, Viola ; Tolokán, Antal ; Egresi, Andrea ; Pap, Tímea ; Horvai, George ; Balogh-Nemes, Katalin ; Klebovich, Imre</creatorcontrib><description>A highly sensitive high-performance liquid chromatographic-tandem mass spectrometric method (HPLC–MS–MS) has been developed to quantitate clemastine in human plasma for the purpose of pharmacokinetic studies. Sample preparation was carried out by liquid–liquid extraction using deuterated clemastine as an internal standard. Chromatographic separation used a C18 reversed phase polymer column giving an extremely fast total run time of 2 min. The method was validated and used for the bioequivalence study of clemastine tablets in healthy male volunteers ( n = 28). The lower limit of detection proved to be 0.01 ng/ml for clemastine.</description><identifier>ISSN: 1570-0232</identifier><identifier>EISSN: 1873-376X</identifier><identifier>DOI: 10.1016/j.jchromb.2004.11.025</identifier><identifier>PMID: 15664345</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Analysis ; Analytical, structural and metabolic biochemistry ; Antihistamine ; Biological and medical sciences ; Chromatography, High Pressure Liquid - methods ; Clemastine ; Clemastine - blood ; Clemastine - pharmacokinetics ; Deuterium ; Drug Stability ; Fundamental and applied biological sciences. Psychology ; General pharmacology ; High-performance liquid chromatography-tandem mass spectrometry ; Histamine H1 Antagonists - blood ; Histamine H1 Antagonists - pharmacokinetics ; Humans ; Male ; Medical sciences ; Pharmacology. Drug treatments ; Reference Standards ; Reproducibility of Results ; Spectrometry, Mass, Electrospray Ionization - methods ; Therapeutic Equivalency</subject><ispartof>Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2005-02, Vol.816 (1), p.153-159</ispartof><rights>2004 Elsevier B.V.</rights><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c422t-592d082d1c890fac1998db1ad41c935be3aa2281ff9081dbb245ed6738f3964e3</citedby><cites>FETCH-LOGICAL-c422t-592d082d1c890fac1998db1ad41c935be3aa2281ff9081dbb245ed6738f3964e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1570023204009419$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=16451370$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15664345$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Horváth, Viola</creatorcontrib><creatorcontrib>Tolokán, Antal</creatorcontrib><creatorcontrib>Egresi, Andrea</creatorcontrib><creatorcontrib>Pap, Tímea</creatorcontrib><creatorcontrib>Horvai, George</creatorcontrib><creatorcontrib>Balogh-Nemes, Katalin</creatorcontrib><creatorcontrib>Klebovich, Imre</creatorcontrib><title>High-performance liquid chromatographic-tandem mass spectrometric method for the determination of clemastine in human plasma</title><title>Journal of chromatography. B, Analytical technologies in the biomedical and life sciences</title><addtitle>J Chromatogr B Analyt Technol Biomed Life Sci</addtitle><description>A highly sensitive high-performance liquid chromatographic-tandem mass spectrometric method (HPLC–MS–MS) has been developed to quantitate clemastine in human plasma for the purpose of pharmacokinetic studies. Sample preparation was carried out by liquid–liquid extraction using deuterated clemastine as an internal standard. Chromatographic separation used a C18 reversed phase polymer column giving an extremely fast total run time of 2 min. The method was validated and used for the bioequivalence study of clemastine tablets in healthy male volunteers ( n = 28). The lower limit of detection proved to be 0.01 ng/ml for clemastine.</description><subject>Analysis</subject><subject>Analytical, structural and metabolic biochemistry</subject><subject>Antihistamine</subject><subject>Biological and medical sciences</subject><subject>Chromatography, High Pressure Liquid - methods</subject><subject>Clemastine</subject><subject>Clemastine - blood</subject><subject>Clemastine - pharmacokinetics</subject><subject>Deuterium</subject><subject>Drug Stability</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>General pharmacology</subject><subject>High-performance liquid chromatography-tandem mass spectrometry</subject><subject>Histamine H1 Antagonists - blood</subject><subject>Histamine H1 Antagonists - pharmacokinetics</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Reference Standards</subject><subject>Reproducibility of Results</subject><subject>Spectrometry, Mass, Electrospray Ionization - methods</subject><subject>Therapeutic Equivalency</subject><issn>1570-0232</issn><issn>1873-376X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkUtrFjEUhoMotlZ_gpKN7mbMdS4rkaJWKLhRcBcyyUknH5PJNMkIgj_e1G-gS1cnkOd9T3iC0GtKWkpo9_7UnsycYphaRohoKW0Jk0_QJR163vC--_m0nmVPGsI4u0Avcj4RQnvS8-fogsquE1zIS_Tnxt_NzQbJxRT0agAv_n73Fv8r1yXeJb3N3jRFrxYCDjpnnDcwpV5DSd7gOuZocS3AZQZsoUAKftXFxxVHh80CNVX8CtiveN7rGrwtOgf9Ej1zesnw6phX6MfnT9-vb5rbb1--Xn-8bYxgrDRyZJYMzFIzjMRpQ8dxsBPVVlAzcjkB15qxgTo3koHaaWJCgu16Pjg-dgL4FXp37t1SvN8hFxV8NrAseoW4Z1XRnnHBKijPoEkx5wRObckHnX4rStSDdnVSh3b1oF1Rqqr2mntzLNinAPYxdXiuwNsD0NnoxaWq2udHrhOS8p5U7sOZg6rjl4eksvFQv8X6VJ0rG_1_nvIXkcOmWg</recordid><startdate>20050225</startdate><enddate>20050225</enddate><creator>Horváth, Viola</creator><creator>Tolokán, Antal</creator><creator>Egresi, Andrea</creator><creator>Pap, Tímea</creator><creator>Horvai, George</creator><creator>Balogh-Nemes, Katalin</creator><creator>Klebovich, Imre</creator><general>Elsevier B.V</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20050225</creationdate><title>High-performance liquid chromatographic-tandem mass spectrometric method for the determination of clemastine in human plasma</title><author>Horváth, Viola ; Tolokán, Antal ; Egresi, Andrea ; Pap, Tímea ; Horvai, George ; Balogh-Nemes, Katalin ; Klebovich, Imre</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c422t-592d082d1c890fac1998db1ad41c935be3aa2281ff9081dbb245ed6738f3964e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Analysis</topic><topic>Analytical, structural and metabolic biochemistry</topic><topic>Antihistamine</topic><topic>Biological and medical sciences</topic><topic>Chromatography, High Pressure Liquid - methods</topic><topic>Clemastine</topic><topic>Clemastine - blood</topic><topic>Clemastine - pharmacokinetics</topic><topic>Deuterium</topic><topic>Drug Stability</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>General pharmacology</topic><topic>High-performance liquid chromatography-tandem mass spectrometry</topic><topic>Histamine H1 Antagonists - blood</topic><topic>Histamine H1 Antagonists - pharmacokinetics</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Reference Standards</topic><topic>Reproducibility of Results</topic><topic>Spectrometry, Mass, Electrospray Ionization - methods</topic><topic>Therapeutic Equivalency</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Horváth, Viola</creatorcontrib><creatorcontrib>Tolokán, Antal</creatorcontrib><creatorcontrib>Egresi, Andrea</creatorcontrib><creatorcontrib>Pap, Tímea</creatorcontrib><creatorcontrib>Horvai, George</creatorcontrib><creatorcontrib>Balogh-Nemes, Katalin</creatorcontrib><creatorcontrib>Klebovich, Imre</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of chromatography. B, Analytical technologies in the biomedical and life sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Horváth, Viola</au><au>Tolokán, Antal</au><au>Egresi, Andrea</au><au>Pap, Tímea</au><au>Horvai, George</au><au>Balogh-Nemes, Katalin</au><au>Klebovich, Imre</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>High-performance liquid chromatographic-tandem mass spectrometric method for the determination of clemastine in human plasma</atitle><jtitle>Journal of chromatography. B, Analytical technologies in the biomedical and life sciences</jtitle><addtitle>J Chromatogr B Analyt Technol Biomed Life Sci</addtitle><date>2005-02-25</date><risdate>2005</risdate><volume>816</volume><issue>1</issue><spage>153</spage><epage>159</epage><pages>153-159</pages><issn>1570-0232</issn><eissn>1873-376X</eissn><abstract>A highly sensitive high-performance liquid chromatographic-tandem mass spectrometric method (HPLC–MS–MS) has been developed to quantitate clemastine in human plasma for the purpose of pharmacokinetic studies. Sample preparation was carried out by liquid–liquid extraction using deuterated clemastine as an internal standard. Chromatographic separation used a C18 reversed phase polymer column giving an extremely fast total run time of 2 min. The method was validated and used for the bioequivalence study of clemastine tablets in healthy male volunteers ( n = 28). The lower limit of detection proved to be 0.01 ng/ml for clemastine.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>15664345</pmid><doi>10.1016/j.jchromb.2004.11.025</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1570-0232
ispartof Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2005-02, Vol.816 (1), p.153-159
issn 1570-0232
1873-376X
language eng
recordid cdi_proquest_miscellaneous_67372342
source MEDLINE; Elsevier ScienceDirect Journals
subjects Analysis
Analytical, structural and metabolic biochemistry
Antihistamine
Biological and medical sciences
Chromatography, High Pressure Liquid - methods
Clemastine
Clemastine - blood
Clemastine - pharmacokinetics
Deuterium
Drug Stability
Fundamental and applied biological sciences. Psychology
General pharmacology
High-performance liquid chromatography-tandem mass spectrometry
Histamine H1 Antagonists - blood
Histamine H1 Antagonists - pharmacokinetics
Humans
Male
Medical sciences
Pharmacology. Drug treatments
Reference Standards
Reproducibility of Results
Spectrometry, Mass, Electrospray Ionization - methods
Therapeutic Equivalency
title High-performance liquid chromatographic-tandem mass spectrometric method for the determination of clemastine in human plasma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T12%3A18%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=High-performance%20liquid%20chromatographic-tandem%20mass%20spectrometric%20method%20for%20the%20determination%20of%20clemastine%20in%20human%20plasma&rft.jtitle=Journal%20of%20chromatography.%20B,%20Analytical%20technologies%20in%20the%20biomedical%20and%20life%20sciences&rft.au=Horv%C3%A1th,%20Viola&rft.date=2005-02-25&rft.volume=816&rft.issue=1&rft.spage=153&rft.epage=159&rft.pages=153-159&rft.issn=1570-0232&rft.eissn=1873-376X&rft_id=info:doi/10.1016/j.jchromb.2004.11.025&rft_dat=%3Cproquest_cross%3E67372342%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67372342&rft_id=info:pmid/15664345&rft_els_id=S1570023204009419&rfr_iscdi=true